NCT01650194 A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients Status COMPLETED Phase PHASE2
NCT01649635 Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer Status COMPLETED Phase PHASE4
NCT01637402 A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT01622439 Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT01621386 Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513) Status COMPLETED Phase PHASE1
NCT01612377 Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis Status TERMINATED Phase PHASE2
NCT01605227 Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100 Status COMPLETED Phase PHASE3
NCT01603407 Finding the Optimum Regimen for Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE3
NCT01594918 Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT01579110 Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia. Status UNKNOWN Phase PHASE2
NCT01578655 Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer Status COMPLETED Phase PHASE3
NCT01576172 Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE2
NCT01569204 Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Classical Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT01539174 Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated High- or High-Intermediate-Risk Diffuse Large B-Cell Lymphoma Status WITHDRAWN Phase PHASE2
NCT01523977 Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL Status COMPLETED Phase PHASE1
NCT01522443 Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer Status TERMINATED Phase PHASE3